EMA Seeks to Revise Guidance on First-In-Human Trials
July 22, 2016
The European Medicines Agency (EMA) is proposing changes to the current guidelines on first-in-human clinical trials to improve risk-based strategies. This proposal was made with cooperation from the European Commission and the Member States of the European Union (EU).
Read the full release here
Recent Videos
Related Content
Is Artificial Intelligence a ‘Product’? Products Liability Implications for AI-Based Products
April 10th 2025Article
As the physical products we use evolve to become increasingly complex, traditional products liability frameworks may not always fit to provide remedies for harm that can result from using novel product types.
